Amedica, a spinal and reconstructive medical device manufacturer, has received 510(k) clearance from the FDA to legally market a second generation family of cervical and lumbar interbody fusion devices manufactured with the company's proprietary silicon nitride biomaterial. The product portfolio expansion offers design enhancements including a threaded insertion feature, additional footprints and design elements that will allow surgeons to perform minimally invasive and lumbar lateral interbody fusion approaches.
More Articles on Orthopedic Devices:
Smith Nephew Updates Indications for Birmingham Hip Implants
Biomet Announces Lifetime Warranty on Oxford Partial Knee
EOS imaging Announces First Installation in Asia